These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23088739)

  • 1. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
    Huygh J; Verhaegen A; Goethals K; Cosyns P; De Block C; Van Gaal L
    Crim Behav Ment Health; 2015 Jul; 25(3):226-30. PubMed ID: 25851640
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for those who have sexually offended or are at risk of offending.
    Khan O; Ferriter M; Huband N; Powney MJ; Dennis JA; Duggan C
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007989. PubMed ID: 25692326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Dekker A; Briken P
    World J Biol Psychiatry; 2014 Aug; 15(6):472-8. PubMed ID: 24219802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics.
    Czerny JP; Briken P; Berner W
    Eur Psychiatry; 2002 Apr; 17(2):104-6. PubMed ID: 11973119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacological treatment of paraphilias and sex offenders.
    Hill A; Briken P; Kraus C; Strohm K; Berner W
    Int J Offender Ther Comp Criminol; 2003 Aug; 47(4):407-21. PubMed ID: 12971182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments for paraphilic patients and sexual offenders.
    Briken P; Kafka MP
    Curr Opin Psychiatry; 2007 Nov; 20(6):609-13. PubMed ID: 17921764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of paraphilias.
    Assumpção AA; Garcia FD; Garcia HD; Bradford JM; Thibaut F
    Psychiatr Clin North Am; 2014 Jun; 37(2):173-81. PubMed ID: 24877704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation treatment of sexual behavior.
    Houts FW; Taller I; Tucker DE; Berlin FS
    Adv Psychosom Med; 2011; 31():149-163. PubMed ID: 22005210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin].
    Briken P; Welzel K; Habermann N; Hill A; Berner W
    Psychiatr Prax; 2009 Jul; 36(5):232-7. PubMed ID: 19437383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-therapy with sexual offenders].
    Stompe T
    Neuropsychiatr; 2007; 21(1):12-7. PubMed ID: 17555003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
    Sauter J; Turner D; Briken P; Rettenberger M
    Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of sexual offenders in German outpatient treatment centers.
    Turner D; Gregório Hertz P; Sauter J; Briken P; Rettenberger M
    Int Clin Psychopharmacol; 2018 Nov; 33(6):349-352. PubMed ID: 29738426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
    Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
    J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of paraphilic and nonparaphilic sexual disorders.
    Guay DR
    Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.